Losartan potassium

This classification denotes an angiotensin ii receptor antagonist with the molecular formula C22H22ClN6O.K, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3ST302B24A, chemically known as 2-butyl-4-chloro-1-(p-(o-1h-tetrazol-5-ylphenyl)benzyl)imidazole-5-methanol, monopotassium salt but more generally known as losartan potassium, which bears US NIH Compound Identifier 60771. European Medicines Agency schedules Losartan potassium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02974MIG. Most nations, for tariff and trade purposes, schedule losartan potassium under HS 29332990 and SITC 51573. As of Q4 2014, LOSARTAN POTASSIUM remains US FDA's Preferred Term for this commodity. Losartan potassium bears US NLM identifiers UMLS ID C0700492 and NCI Concept Code C29165. SMILES: CCCCC1NC(C(N1CC2CCC(CC2)C3CCCCC3C4[N-]NNN4)CO)CL.[K+].